CVE-2022-39054: Cowell enterprise travel management system has insufficient filtering for special characters within web URL
CVE-2022-39054 is a medium-severity flaw (CVSS 6.1) affecting cowell enterprise travel management system. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Cowell enterprise travel management system has insufficient filtering for special characters within web URL. An unauthenticated remote attacker can inject JavaScript and perform XSS (Reflected Cross-Site Scripting) attack.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 0.6% (top 50%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2022-09-28 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2022-39054?
cowell enterprise travel management system: mitigate or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2022-39054 being exploited?
CVE-2022-39054 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2022-39054 affect?
CVE-2022-39054 affects cowell enterprise travel management system. Severity is medium (CVSS 6.1). Cowell enterprise travel management system has insufficient filtering for special characters within web URL. An unauthenticated remote attacker can inject JavaScript and perform XSS (Reflected Cross-Site Scripting) attack.
How urgent is CVE-2022-39054?
Priority 34/100. No elevated risk signals yet.